Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is often diagnosed at an advanced stage when surgical options are limited. In recent years, non-surgical treatments have emerged as crucial tools in managing advanced hepatocellular carcinoma, offering hope to patients who are not candidates for surgery.